Topic: The New England Journal Of Medicine
A cocktail of three drugs, including a new class of antiviral agent, has shown encouraging results in treating hepatitis C, a disease which attacks the liver, a study said Wednesday."This study represents a remarkable advance and a potential cure for people with ...
Phase 2 clinical trials of treatment regimens based on telaprevir in combination with peginterferon alfa-2a and ribavirin show significantly improved virologic responses in chronic hepatitis C virus patients, according to two studies published in the April 30 issue of the New England ...
Long-term therapy with peginterferon does not prevent liver disease progression in hepatitis C patients who had no response to initial treatment with peginterferon and ribavirin, researchers report in the Dec. 4 issue of the New England Journal of Medicine.. Adrian M. Di ...
Research published in the June 5 issue of the Canadian Medical Association Journal, which used data from the National Longitudinal Survey of Children and Youth (1994 to 2000), reports that kids whose parents divorced were twice as likely to be prescribed Ritalin ...
Photo Gallery
From Around the Web
Video Gallery
-
The New England Journal of Medicine ...
A brief video introducing the redesigned NEJM.org with commentary ...2010-07-29 -
New England Journal of Medicine Article- ...
Brief critique of the 2000 Cherkin and Deyo article comparing ...2009-12-06 -
New England Journal of Medicine Publishes ...
Sound Bites: Dr. Kevin Ault, Emory University School of Medicine2007-05-09
